Pay in 4 interest-free payments of $6.00 Learn more
Ships within 48 hours · Estimated delivery Oct 17 - Oct 22
Oral d-allulose (1 g kg 1 ), injected 1 h prior to i.p
Initially approved for Type 2 diabetes, it has since gained accelerated traction as an anti-obesity drug (under the name Zepbound)
Acute symptoms such as fatigue may improve within days, whilst neurological symptoms like paraesthesia typically require weeks to months of treatment
This characteristic makes dihexa a compelling subject for ongoing and future research in neuropharmacology
| 2003 | ANZ Journal of Surgery Disclaimer: The above information is for research and educational purposes only and not a substitute for professional medical advice
US$ 27.83
US$ 23.63
US$ 22.85
US$ 29.19
US$ 26.19
